BLIS Technologies Ltd. | |
Stock Exchange | New Zealand Stock Exchange |
EPS |
NZD0 |
Market Cap |
NZD39.88 M |
Shares Outstanding |
1.11 B |
Public Float |
- |
Address |
81 Glasgow Street Dunedin OT 9012 New Zealand |
Employees | - |
Website | http://www.blis.co.nz |
Updated | 07/08/2019 |
BLIS Technologies Ltd. engages in the development of healthcare products based on strains of bacteria that produce Bacteriocin activity. It operates in the following geographical areas: Australasia, Asia (including China), Europe, and North America. The company was founded in June 2000 and is headquartered in Dunedin, New Zealand. |